Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

NCT01300143 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01300143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01300143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
October 26, 2018
Enrollment
126 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma